The Warburg therapy's use of insulin pharmacologically induces hypoglycemia overcoming dietary compliance issues while creating a period where cancerous tumors are deprived of much of their needed glycose so they can be treated with chemotherapy. The gene discussed is INS; the disease is Hypoglycemia.